Iida Group Holdings Co., Ltd. (TYO:3291)

Verve Therapeutics Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	588,031	630,172	558,935	610,069	609,922	771,706
Market Cap Growth	12.75%	12.75%	-8.38%	0.02%	-20.96%	78.76%
Enterprise Value	734,841	831,864	825,823	772,901	538,446	705,357
Last Close Price	2128.00	2280.50	1917.83	1994.42	1870.10	2283.10
PE Ratio	11.75	12.43	15.02	8.07	5.90	9.26
Forward PE	10.76	11.02	11.25	7.40	5.79	10.19
PS Ratio	0.40	0.43	0.39	0.42	0.44	0.53
PB Ratio	0.60	0.64	0.57	0.63	0.66	0.90
P/TBV Ratio	0.78	0.84	0.75	0.83	0.87	1.18
P/FCF Ratio	7.83	8.39	-	-	-	2.44
P/OCF Ratio	6.37	6.83	-	-	195.80	2.39
PEG Ratio	1.71	2.68	2.68	-	0.71	10.19
EV/Sales Ratio	0.50	0.57	0.57	0.54	0.39	0.48
EV/EBITDA Ratio	7.61	8.62	11.05	6.59	3.27	5.50
EV/EBIT Ratio	9.25	10.47	14.08	7.66	3.51	5.96
EV/FCF Ratio	9.79	11.08	-	-	-	2.23
Debt / Equity Ratio	0.66	0.66	0.64	0.57	0.56	0.49
Debt / EBITDA Ratio	6.71	6.71	8.27	4.72	3.18	3.29
Debt / FCF Ratio	8.62	8.62	-	-	-	1.33
Asset Turnover	0.80	0.80	0.81	0.83	0.88	0.97
Inventory Turnover	1.53	1.53	1.56	1.73	2.00	2.04
Quick Ratio	1.11	1.11	0.95	1.03	1.33	1.58
Current Ratio	2.84	2.84	2.71	2.67	2.70	2.88
Return on Equity (ROE)	5.03%	5.03%	3.72%	7.98%	11.61%	10.13%
Return on Assets (ROA)	2.71%	2.71%	2.05%	3.65%	6.05%	4.92%
Return on Capital (ROIC)	3.09%	3.09%	2.36%	4.24%	7.02%	5.65%
Return on Capital Employed (ROCE)	5.80%	5.80%	4.40%	7.80%	12.50%	10.80%
Earnings Yield	8.62%	8.04%	6.66%	12.39%	16.95%	10.80%
FCF Yield	12.77%	11.91%	-5.97%	-15.15%	-1.86%	41.03%
Dividend Yield	4.24%	3.95%	4.69%	4.51%	4.81%	3.24%
Payout Ratio	49.77%	49.77%	68.04%	34.17%	24.55%	21.46%
Buyback Yield / Dilution	0.28%	0.28%	1.90%	0.80%	0.00%	0.00%
Total Shareholder Return	4.55%	4.23%	6.59%	5.32%	4.81%	3.24%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.